**Acknowledgements**

The authors would like to thank the Institute for Research and Community Services (LPPM) of Indonesia International Institute for Life Sciences (I3L) for their heartfelt support. Thanks also go to the Indonesian Society for Bioinformatics and Biodiversity (ISBB) or *Masyarakat Bioinformatika dan Biodiversitas Indonesia* (MABBI) members and leaders for the thorough forum group discussion on the topic of COVID-19 pandemic, artificial intelligence for drug design, and molecular docking validation.
